Adenosine receptors and L-DOPA-induced dyskinesia in Parkinson's disease: potential targets for a new therapeutic approach

Exp Neurol. 2003 Dec;184(2):556-60. doi: 10.1016/S0014-4886(03)00402-3.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Animals
  • Antiparkinson Agents / adverse effects*
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • Dyskinesias / drug therapy*
  • Dyskinesias / etiology
  • Humans
  • Levodopa / adverse effects*
  • Parkinson Disease / drug therapy*
  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1 / drug effects
  • Receptors, Purinergic P1 / metabolism*

Substances

  • Antiparkinson Agents
  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1
  • Levodopa